Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on West Pharmaceutical Services

Related WST
CR Bard's Lutonix DCB Moves Closer To FDA Clearance - Analyst Blog
Cooper Cos Up on Q2 Earnings Beat - Analyst Blog

In a report published Monday, Jefferies & Company reiterated its Hold rating on West Pharmaceutical Services (NYSE: WST), and raised its price target from $45.00 to $49.00.

Jefferies noted, “WST continues to see progress in shifting customers to high value (and higher margin) packaging products. The company has also benefited from accelerated demand from clients, who are building inventory and launching new products. We expected that to moderate sooner than now, but still expect it to diminish in the future. We are raising EPS based on the recent performance, while maintaining future growth rates.”

West Pharmaceutical Services closed on Friday at $52.66.

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (WST)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional